Home › Compare › TRXPF vs MO

TRXPF vs MO: Dividend Comparison 2026

TRXPF yields 3.27% · MO yields 6.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TRXPF wins by $634.86M in total portfolio value
10 years
TRXPF
TRXPF
● Live price
3.27%
Share price
$24.57
Annual div
$0.80
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$634.94M
Annual income
$599,684,359.43
Full TRXPF calculator →
MO
Altria Group Inc.
● Live price
6.36%
Share price
$65.99
Annual div
$4.20
5Y div CAGR
22.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$80.1K
Annual income
$30,159.17
Full MO calculator →

Portfolio growth — TRXPF vs MO

📍 TRXPF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTRXPFMO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TRXPF + MO cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
TRXPF pays
MO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TRXPF
Annual income on $10K today (after 15% tax)
$277.78/yr
After 10yr DRIP, annual income (after tax)
$509,731,705.52/yr
MO
Annual income on $10K today (after 15% tax)
$540.99/yr
After 10yr DRIP, annual income (after tax)
$25,635.29/yr
At 15% tax rate, TRXPF beats the other by $509,706,070.22/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TRXPF + MO for your $10,000?

TRXPF: 50%MO: 50%
100% MO50/50100% TRXPF
Portfolio after 10yr
$317.51M
Annual income
$299,857,259.29/yr
Blended yield
94.44%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MO right now

TRXPF
No analyst data
Altman Z
5.8
Piotroski
3/9
MO
Analyst Ratings
16
Buy
9
Hold
1
Sell
Consensus: Buy
Price Target
$61.25
-7.2% upside vs current
Range: $47.00 — $68.00
Altman Z
3.2
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TRXPF buys
0
MO buys
0
No recent congressional trades found for TRXPF or MO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTRXPFMO
Forward yield3.27%6.36% ✓
Annual dividend / share$0.80$4.20 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100% ✓22.6%
Portfolio after 10y$634.94M ✓$80.1K
Annual income after 10y$599,684,359.43 ✓$30,159.17
Total dividends collected$632.35M ✓$74.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: TRXPF vs MO ($10,000, DRIP)

YearTRXPF PortfolioTRXPF Income/yrMO PortfolioMO Income/yrGap
1← crossover$11,354$653.59$10,570$780.30+$784.00 → TRXPF
2$13,535$1,387.04$11,381$1,032.90+$2.2K → TRXPF
3$17,574$3,090.80$12,535$1,392.73+$5.0K → TRXPF
4$26,305$7,500.82$14,193$1,920.91+$12.1K → TRXPF
5$49,132$20,985.78$16,618$2,723.68+$32.5K → TRXPF
6$125,837$73,265.77$20,263$3,993.80+$105.6K → TRXPF
7$485,391$350,745.93$25,936$6,098.36+$459.5K → TRXPF
8$3,048,220$2,528,851.81$35,166$9,775.01+$3.01M → TRXPF
9$32,945,707$29,684,110.82$51,026$16,597.78+$32.89M → TRXPF
10$634,936,266$599,684,359.43$80,113$30,159.17+$634.86M → TRXPF

TRXPF vs MO: Complete Analysis 2026

TRXPF — Stock

Torii Pharmaceutical Co., Ltd. manufactures and markets pharmaceutical products in Japan. It offers therapeutic agents, such as Riona for the treatment of hyperphosphatemia; and REMITCH, an oral therapeutic agent used for the treatment of pruritus in dialysis and liver disease patients. The company also provides ANTEBATE that is used for the treatment of skin diseases, such as atopic dermatitis and contact dermatitis by reducing inflammation; allergen immunotherapy tablets comprising CEDARCURE and MITICURE; and CORECTIM, a topical janus kinase (JAK) inhibitor. It markets its products primarily through medical representatives for medical professionals. The company was formerly known as Torii Shoten K.K and changed its name to Torii Pharmaceutical Co., Ltd. in May 1949. The company was founded in 1872 and is headquartered in Tokyo, Japan. Torii Pharmaceutical Co., Ltd. is a subsidiary of Japan Tobacco Inc.

Full TRXPF Calculator →

MO — Consumer Staples

Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. The company provides cigarettes primarily under the Marlboro brand; cigars and pipe tobacco principally under the Black & Mild brand; and moist smokeless tobacco products under the Copenhagen, Skoal, Red Seal, and Husky brands, as well as provides on! oral nicotine pouches. It sells its tobacco products primarily to wholesalers, including distributors; and large retail organizations, such as chain stores. Altria Group, Inc. was founded in 1822 and is headquartered in Richmond, Virginia.

Full MO Calculator →
📬

Get this TRXPF vs MO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TRXPF vs SCHDTRXPF vs JEPITRXPF vs OTRXPF vs KOTRXPF vs MAINTRXPF vs PMTRXPF vs BTITRXPF vs PG

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.